PHDS HEALTHCARE RESEARCH Co., Ltd.
Broadcasting Star won two awards at the '2017 Integrity China' event.
Release time:
2018-01-18
From January 18 to 19, 2018, the "2018 China Reform Innovation and Integrity Construction Achievement Tour Theme Event" organized by relevant departments of the National Development and Reform Commission was held at the Diaoyutai State Guesthouse in Beijing.
From January 18 to 19, 2018, the "2018 China Reform Innovation and Integrity Construction Achievement Tour Theme Event" organized by relevant departments of the National Development and Reform Commission was held at the Diaoyutai State Guesthouse in Beijing. During the event, a grand award ceremony was held for 500 domestic enterprises. Among them, there were 28 Fortune Global 500 companies, 75 domestic top 500 companies, and 18 health enterprises. Our company's president was awarded the title of "2017 China Integrity Entrepreneur", and Boshi Star Pharmaceutical Technology Co., Ltd. was awarded the title of "2017 Integrity China Demonstration Unit". "Integrity China" is the highest honor in the current context of reform and opening up! The company and all employees will cherish this honor as if it were their own eyes!
In 2018, the country celebrated the 40th anniversary of reform and opening up. This event deeply implemented the spirit of the "National Innovation-Driven Development Strategy Outline" by the Central Committee of the Communist Party of China and the State Council, and carried out the directive spirit of solemnly commemorating the 40th anniversary of reform and opening up. By creating a platform for evaluation, discussion, and experience sharing on reform innovation and integrity construction, it promotes the development and construction of Chinese enterprises and contributes to the realization of the great rejuvenation of the Chinese nation.
During the event, the organizer released the "2018 China Reform Innovation and Integrity Construction Public Opinion Monitoring and Evaluation Report", which was interpreted by Song Chengmin, Secretary of the Macro-Economic Management Editorial Department of the National Development and Reform Commission. In terms of reform and innovation, the report pointed out that in recent years, China's innovation capability has been evident, yielding rich results. New economies and new business models such as "Internet+" and "sharing economy" are thriving, continuously changing various aspects of people's lives, and have become a new business card for China in the international community. In the face of the new normal, Chinese enterprises should seek momentum from reform, potential from transformation, and vitality from innovation, adhering to the principles of seeking newness in change, progress in newness, and breakthroughs in advancement, striving to find a path of transformation and innovative development. In terms of integrity construction, the report pointed out that the lifespan of Chinese enterprises is generally short. Data shows that the average lifespan of Chinese enterprises is about 5 years, and the average lifespan of some small enterprises does not exceed 3 years, with nearly 1 million enterprises closing down each year in recent years. There are many reasons for the closure of these enterprises, among which, in addition to the lack of innovation, unwillingness to change, and unsustainable operations, an important reason is the lack of integrity, which leads to self-destruction of the brand and cutting off financial resources.
Keyword:
Previous article
Relevant regulations and policies
Key points and judgment principles for the quality management of non-clinical research of drugs
In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."
2024-11-22
Technical requirements for the latest declaration data electronic disc
In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.
2024-11-22
In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.
2024-11-22
On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.
2024-11-22
What if you have more needs?
Leave your demand information online and we will reply to you in time!
Contact Information
Customer service hotline:
E-mail:customer@cnphds.com
Address: Building A, Ocean Express,66 Xia Guang Li, Dong San Huan North Road,Chaoyang district, Beijing, China
Mobile
Public Number
京公网安备11010502056452号